beta-lactams has been researched along with 6,7-dihydroxyflavone in 1 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (6,7-dihydroxyflavone) | Trials (6,7-dihydroxyflavone) | Recent Studies (post-2010) (6,7-dihydroxyflavone) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 177 | 0 | 167 |
| Protein | Taxonomy | beta-lactams (IC50) | 6,7-dihydroxyflavone (IC50) |
|---|---|---|---|
| Aromatase | Homo sapiens (human) | 0.0087 | |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 3.98 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakaki, N; Higuti, T; Sato, Y; Shibata, H | 1 |
1 other study(ies) available for beta-lactams and 6,7-dihydroxyflavone
| Article | Year |
|---|---|
6,7-dihydroxyflavone dramatically intensifies the susceptibility of methicillin-resistant or -sensitive Staphylococcus aureus to beta-lactams.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Colony Count, Microbial; Drug Synergism; Flavones; Flavonoids; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2004 |